Latest News

Teshamae Monteith, MD, FAHS, FAAN, associate professor of clinical neurology and chief of the headache division in the department of neurology at the University of Miami Miller School of Medicine
Survey Data Highlights Real-World Use of Rimegepant for Short-Term Migraine Prevention

July 8th 2025

A recent survey reveals rimegepant's effectiveness for short-term migraine prevention, highlighting user demographics, triggers, and treatment strategies.

SUNRISE Trial Confirms Effectiveness of Eptinezumab in Asian Population With Chronic Migraine
SUNRISE Trial Confirms Effectiveness of Eptinezumab in Asian Population With Chronic Migraine

July 8th 2025

Predicting Amyloid Positivity with CARM: Clinical Insights from James Galvin, MD, MPH
Predicting Amyloid Positivity with CARM: Clinical Insights from James Galvin, MD, MPH

July 7th 2025

FDA Grants Priority Review, Sets PDUFA Date for Hunter Syndrome Treatment Tividenofusp Alfa
FDA Grants Priority Review, Sets PDUFA Date for Hunter Syndrome Treatment Tividenofusp Alfa

July 7th 2025

This Week on NeurologyLive® — July 7, 2025
This Week on NeurologyLive® — July 7, 2025

July 7th 2025

Coverage of SLEEP 2025

Get direct access to interviews with experts, straight from the conference floor in Seattle, as well as the latest data and clinical news updates.

SLEEP 2025

Conference Coverage

View All
SUNRISE Trial Confirms Effectiveness of Eptinezumab in Asian Population With Chronic Migraine
SUNRISE Trial Confirms Effectiveness of Eptinezumab in Asian Population With Chronic Migraine

July 8th 2025

Advancing Research and Drug Development for Isolated RBD: Emmanuel During, MD
Advancing Research and Drug Development for Isolated RBD: Emmanuel During, MD

July 8th 2025

Recognizing Gastrointestinal Symptoms as Early Indicators of Parkinson Disease
Recognizing Gastrointestinal Symptoms as Early Indicators of Parkinson Disease

July 4th 2025

Reduction in Parkinson OFF Episodes Through Subcutaneous Apomorphine Infusion Leads to Doubling of Good ON Time
Reduction in Parkinson OFF Episodes Through Subcutaneous Apomorphine Infusion Leads to Doubling of Good ON Time

July 3rd 2025

Video Series
Video Interviews
Podcasts

Most Recent

© 2025 MJH Life Sciences

All rights reserved.